Clinical Characteristics of PMS Co-Morbid with MDD and Effectiveness of SSRIs in its Treatment
Background: Data on the clinical characteristics of premenstrual syndrome (PMS) with co-morbid major depressive disorder (MDD) are scarce. Although selective serotonin re-uptake inhibitors (SSRIs) are widely used to treat both PMS and MDD there is little information on their efficacy in PMS in patie...
Guardado en:
Autores principales: | Yakimova R., Stoimenova-Popova M., Chumpalova P., Pandova M., Stoyanova M. |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Sciendo
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/095ebc5f28aa4dba9c2aa350974659ce |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Early symptom non-improvement and aggravation are associated with the treatment response to SSRIs in MDD: a real-world study
por: Yuan H, et al.
Publicado: (2019) -
Degradation of organic contaminants in the CoFe2O4/peroxymonosulfate process: The overlooked role of Co(II)-PMS complex
por: Xinhong Li, et al.
Publicado: (2021) -
Trastorno disfórico premenstrual
por: López-Mato,Andrea, et al.
Publicado: (2000) -
Psychiatric morbidity in individuals with permanent orthopedic disability
por: Ajay Kumar, et al.
Publicado: (2021) -
The change of gut microbiota in MDD patients under SSRIs treatment
por: Yang Shen, et al.
Publicado: (2021)